Persistence of antibodies to West Nile virus nonstructural protein 5

Journal of Clinical Virology

Volumn 43, Issue 1, 2008, Pages 102-106

  Prince, Harry E ^a   Lapé Nixon, Mary ^a   Yeh, Cindy ^a   Tobler, Leslie H ^b   Busch, Michael P ^b  

^a Focus Diagnostics Inc   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

NS5 antibodies; Persistence; PreM E IgM; West Nile virus

Indexed keywords

ANTIBODY; ENVELOPE PROTEIN; IMMUNOGLOBULIN M; MICROSPHERE; NONSTRUCTURAL PROTEIN 5;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNOASSAY; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SEROLOGY; VIREMIA; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN M; MICROSPHERES; TIME FACTORS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 49749153816     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.03.025     Document Type: Article

References (19)

1. Azzi A., and Lin S.X. Structure function analysis of West Nile virus RNA dependent RNA polymerase: molecular model and implications for drug design. Med Chem 3 (2007) 455-459
2. Busch M.P., Caglioti S., Robertson E.F., McAuley J.D., Tobler L.H., Kamel H., et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 353 (2005) 460-467
3. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and express in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J Virol 75 (2001) 4040-4047
4. Fox J.L., Hazell S.L., Tobler L.H., and Busch M.P. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus. Clin Vaccine Immunol 13 (2006) 33-36
5. Hogrefe W.R., Moore R., Lape-Nixon M., Wagner M., and Prince H.E. The performance of West Nile virus recombinant (preM/E)-based IgG and IgM ELISA for the detection of West Nile virus and other flavivirus antibodies. J Clin Microbiol 42 (2004) 4641-4648
6. Holmes D.A., Purdy D.E., Chao D.Y., Noga A.J., and Chang G.J. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J Clin Microbiol 43 (2005) 3227-3236
7. Martins T.B. Development of internal controls for the luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clin Diagn Lab Immunol 9 (2002) 41-45
8. Muerhoff A.S., Dawson G.J., Dille B., Gutierrez R., Leary T.P., Gupta M.C., et al. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid. Clin Diagn Lab Immunol 11 (2004) 651-657
9. Petersen L.R., and Marfin A.A. West Nile virus: a primer for the clinician. Ann Int Med 137 (2002) 173-179
10. Prince H.E., and Hogrefe W.R. Assays for detecting West Nile virus antibodies in human serum, plasma, and cerebrospinal fluid. Clin Appl Immunol Rev 5 (2005) 45-63
11. Prince H.E., Tobler L.H., Lape-Nixon M., Foster G.A., Stramer S.L., and Busch M.P. Development and persistence of West Nile virus immunoglobulin M (IgM), IgA, and IgG during follow-up of viremic blood donors. J Clin Microbiol 43 (2005) 4316-4320
12. Prince H.E., Lape-Nixon M., Busch M.P., Tobler L.H., Foster G.A., and Stramer S.L. Utilization of follow-up specimens from viremic blood donors to assess the value of West Nile virus immunoglobulin G avidity as an indicator of recent infection. Clin Diagn Lab Immunol 12 (2005) 1123-1126
13. Prince H.E., Tobler L.H., Yeh C., Gefter N., Custer B., and Busch M.P. Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol 14 (2007) 1228-1230
14. Rawlins M.L., Swenson E.M., Hill H.R., and Litwin C.M. Evaluation of an enzyme immunoassay for detection of immunoglobulin M antibodies to West Nile virus and the importance of background subtraction in detecting nonspecific reactivity. Clin Vaccine Immunol 14 (2007) 665-668
15. Roehrig J.T., Nash D., Maldin B., Labowitz A., Martin D.A., Lanciotti R.S., et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 9 (2003) 376-379
16. Sampathkumar P. West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc 78 (2003) 1137-1144
17. Tilley P.A., Walle R., Chow A., Jayaraman G.C., Fonseca K., Debrot M.A., et al. Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile activity, Alberta, Canada. J Clin Microbiol 43 (2005) 4691-4695
18. Wong S.J., Boyle R.H., Demarest V.L., Woodmansee A.N., Kramer L.D., Li H., et al. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 41 (2003) 4217-4223
19. Wong S.J., Demarest V.L., Boyle R.H., Wang T., Ledizet M., Kar K., et al. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42 (2004) 65-72